Financials
- Market Capitalization 369.17 M
- Employee 81
- Founded 1999
- CEO N/A
- Website www.agenusbio.com
- Headquarter Delaware, United States
- FIGI BBG000C8SWQ9
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
1.01
ratio cours/chiffre d'affaires
0.81
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3099 | IRD Opus Genetics, Inc. - Common Stock | 4.50 USD | +1.12% | +16.28% | +22.62% | +20.97% | 374.38 M USD | ||
| 3113 | IPSC Century Therapeutics, Inc. - Common Stock | 2.11 USD | 0.00% | -6.22% | +4.46% | +348.94% | 382.07 M USD | ||
| 3146 | DMAC DiaMedica Therapeutics Inc. - Common Stock | 6.67 USD | -1.19% | +0.30% | +1.06% | +26.09% | 359.68 M USD | ||
| 3159 | LYEL Lyell Immunopharma, Inc. - Common Stock | 14.51 USD | -3.01% | -1.69% | +12.74% | -40.02% | 355.57 M USD |